Skip to main content
. 2017 Jun 26;40(2):474–482. doi: 10.3892/ijmm.2017.3041

Figure 3.

Figure 3

Specific anti-human HSP90β mAb inhibited HSP90β-JEV binding on the cell surface in a dose-dependent manner. (A) HSP90β-JEV binding was exhibited using IFA (magnification, ×400). (B) Histograms of FCM detection at various concentrations of the anti-human HSP90β mAb. (C) HSP90β-JEV binding percentages measured by FCM. **P<0.01. mAb, monoclonal antibody; JEV, Japanese encephalitis virus; FCM, flow cytometry.